FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387160250> ?p ?o ?g. }

• W4387160250 endingPage "e555" @default.
• W4387160250 startingPage "e555" @default.
• W4387160250 abstract "Survival rates for women with metastatic cervical cancer (CC) are low, with limited management options. Radiation therapy (RT) for metastatic disease has led to prolonged survival in other malignancies, however, the data are scarce in CC. Herein, we evaluated the effect of RT for metastatic CC.A total of 58 patients with metastatic CC between September 2019 and January 2023 were retrospectively analyzed. All the patients were treated with platinum-based chemotherapy combined with targeted therapy or immunotherapy followed with or without RT (NRT). The recent efficacy, survival status and prognostic factors were analyzed statistically.Objective response rate (ORR) was 63.6% with one complete and twenty partial responses in RT group (n = 33) and 40.0% with two complete and eight partial responses in NRT group (n = 25), respectively (p = 0.074). Disease control rate (DCR) of the RT and NRT groups were 79.4% vs 80.0%, respectively (p = 0.861). Median follow-up time was 17 months (3-39months). In RT group, 11(33.3%) patients experienced local regional or distant failure and 9 (27.3%) patients were dead. In NRT group, 15(60%) patients had progression and 8 (32%) patients dead. There was no significant difference between the two groups in overall survival (OS); however, RT group displayed superior progression-free survival (PFS) (1-year OS: 72.7% vs. 68.0%, p = 0.460; 1-year PFS: 66.7% vs. 40.0%, p = 0.039). The multivariate analysis showed that RT, immunotherapy, lymph node metastasis only relevant predictor of superior PFS but not OS. In subgroup analysis, patients treated with RT appeared to have a better PFS in some specific cohorts, such as age>45 years (72.0% vs 36.4% P = 0.015), squamous carcinoma histology (71.0% vs 40.9% P = 0.017), metastatic at diagnosis (75.0% vs 47.6% P = 0.012), non-targeted therapy (72.4% vs 43.8% P = 0.040). No significant increase in treatment-related toxicity was observed in the RT group compared with the NRT group.RT provided superior PFS in metastatic CC patients compared to NRT, and well tolerated. Moreover, RT, immunotherapy, lymph node metastasis only were independent significant prognostic factors for PFS. Subgroup analysis showed that combination of RT and chemotherapy obtained favorable PFS in metastatic CC patients with age>45 years, squamous carcinoma histology, metastatic at diagnosis, non-targeted therapy. Studies with a larger sample size and longer follow-up are warranted." @default.
• W4387160250 created "2023-09-30" @default.
• W4387160250 creator A5016340724 @default.
• W4387160250 creator A5024016708 @default.
• W4387160250 creator A5024074365 @default.
• W4387160250 creator A5025180804 @default.
• W4387160250 creator A5036916055 @default.
• W4387160250 creator A5044216882 @default.
• W4387160250 creator A5044757881 @default.
• W4387160250 creator A5049274122 @default.
• W4387160250 creator A5064222660 @default.
• W4387160250 creator A5066411703 @default.
• W4387160250 creator A5068080767 @default.
• W4387160250 date "2023-10-01" @default.
• W4387160250 modified "2023-10-04" @default.
• W4387160250 title "The Role of Radiation Therapy for Metastatic Cervical Cancer" @default.
• W4387160250 doi "https://doi.org/10.1016/j.ijrobp.2023.06.1865" @default.
• W4387160250 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37785704" @default.
• W4387160250 hasPublicationYear "2023" @default.
• W4387160250 type Work @default.
• W4387160250 citedByCount "0" @default.
• W4387160250 crossrefType "journal-article" @default.
• W4387160250 hasAuthorship W4387160250A5016340724 @default.
• W4387160250 hasAuthorship W4387160250A5024016708 @default.
• W4387160250 hasAuthorship W4387160250A5024074365 @default.
• W4387160250 hasAuthorship W4387160250A5025180804 @default.
• W4387160250 hasAuthorship W4387160250A5036916055 @default.
• W4387160250 hasAuthorship W4387160250A5044216882 @default.
• W4387160250 hasAuthorship W4387160250A5044757881 @default.
• W4387160250 hasAuthorship W4387160250A5049274122 @default.
• W4387160250 hasAuthorship W4387160250A5064222660 @default.
• W4387160250 hasAuthorship W4387160250A5066411703 @default.
• W4387160250 hasAuthorship W4387160250A5068080767 @default.
• W4387160250 hasConcept C121608353 @default.
• W4387160250 hasConcept C126322002 @default.
• W4387160250 hasConcept C143998085 @default.
• W4387160250 hasConcept C2776694085 @default.
• W4387160250 hasConcept C2777701055 @default.
• W4387160250 hasConcept C2778220009 @default.
• W4387160250 hasConcept C2780739268 @default.
• W4387160250 hasConcept C38180746 @default.
• W4387160250 hasConcept C509974204 @default.
• W4387160250 hasConcept C71924100 @default.
• W4387160250 hasConcept C90924648 @default.
• W4387160250 hasConceptScore W4387160250C121608353 @default.
• W4387160250 hasConceptScore W4387160250C126322002 @default.
• W4387160250 hasConceptScore W4387160250C143998085 @default.
• W4387160250 hasConceptScore W4387160250C2776694085 @default.
• W4387160250 hasConceptScore W4387160250C2777701055 @default.
• W4387160250 hasConceptScore W4387160250C2778220009 @default.
• W4387160250 hasConceptScore W4387160250C2780739268 @default.
• W4387160250 hasConceptScore W4387160250C38180746 @default.
• W4387160250 hasConceptScore W4387160250C509974204 @default.
• W4387160250 hasConceptScore W4387160250C71924100 @default.
• W4387160250 hasConceptScore W4387160250C90924648 @default.
• W4387160250 hasIssue "2" @default.
• W4387160250 hasLocation W43871602501 @default.
• W4387160250 hasLocation W43871602502 @default.
• W4387160250 hasOpenAccess W4387160250 @default.
• W4387160250 hasPrimaryLocation W43871602501 @default.
• W4387160250 hasRelatedWork W1975479077 @default.
• W4387160250 hasRelatedWork W1988030834 @default.
• W4387160250 hasRelatedWork W2355192833 @default.
• W4387160250 hasRelatedWork W2379629551 @default.
• W4387160250 hasRelatedWork W2381666983 @default.
• W4387160250 hasRelatedWork W2384708512 @default.
• W4387160250 hasRelatedWork W2922707684 @default.
• W4387160250 hasRelatedWork W3030201060 @default.
• W4387160250 hasRelatedWork W4220655021 @default.
• W4387160250 hasRelatedWork W4245694863 @default.
• W4387160250 hasVolume "117" @default.
• W4387160250 isParatext "false" @default.
• W4387160250 isRetracted "false" @default.
• W4387160250 workType "article" @default.